Department of Structural and Computational Biology, Max Perutz Laboratories, University of Vienna, Campus Vienna Biocenter, 5, 1030 Vienna, Austria.
Vienna Doctoral School in Chemistry (DoSChem), University of Vienna, Währingerstraße 38, 1090 Vienna, Austria.
J Am Chem Soc. 2024 Oct 16;146(41):27983-27987. doi: 10.1021/jacs.4c09176. Epub 2024 Oct 7.
Intrinsically disordered proteins are abundant in eukaryotic systems, but they remain largely elusive pharmacological targets. NMR spectroscopy proved to be a suitable method to study these proteins and their interaction with one another or with drug candidates. Although NMR can give atomistic information about these interplays, molecular complexity due to severe spectral overlap, limited sample stability, and quantity remain an issue and hamper widespread applications. Here, we propose an approach to simultaneously map protein-protein binding sites onto two interacting partners by employing a complementary isotope-labeling strategy and a multiple receiver NMR detection scheme. With one partner being N,H labeled and the interacting one being C,H-labeled, we exploited proton and carbon detection to obtain clean and easily readable information. The method is illustrated with an application to the 50 kDa ternary protein complex formed between the prominent oncogenic transcription factor complex Myc/MAX and the tumor suppressor BRCA1.
天然无序蛋白质在真核系统中大量存在,但它们仍然是难以捉摸的药理学靶点。NMR 光谱学被证明是研究这些蛋白质及其与其他药物候选物相互作用的合适方法。尽管 NMR 可以提供关于这些相互作用的原子信息,但由于光谱严重重叠、样品稳定性和数量有限导致的分子复杂性仍然是一个问题,并阻碍了其广泛应用。在这里,我们提出了一种通过使用互补的同位素标记策略和多个接收器 NMR 检测方案,同时将蛋白质-蛋白质结合位点映射到两个相互作用的伙伴上的方法。其中一个伙伴被 N,H 标记,而相互作用的伙伴被 C,H 标记,我们利用质子和碳检测来获得干净且易于读取的信息。该方法应用于由显著的致癌转录因子复合物 Myc/MAX 和肿瘤抑制因子 BRCA1 形成的 50 kDa 三元蛋白质复合物进行了说明。